The PSEN1 Gene Pick Disease Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PSEN1 gene, which are associated with Pick's disease, a type of frontotemporal dementia. This condition is characterized by changes in personality, behavior, and language due to brain cell damage. The PSEN1 gene plays a crucial role in the production of the presenilin 1 protein, involved in the processing of amyloid precursor protein, a substance that, when improperly cleaved, can lead to the accumulation of amyloid plaques, a hallmark of several forms of dementia, including Pick's disease.
The test is conducted through a blood sample, where DNA is extracted and analyzed for specific mutations in the PSEN1 gene. This genetic testing is crucial for individuals with a family history of Pick's disease or early-onset dementia, as it can provide vital information for the management and understanding of the condition. The cost of the PSEN1 Gene Pick Disease Genetic Test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to perform this detailed genetic analysis. Early detection through this test can be instrumental in planning the appropriate care and support for affected individuals and their families.
The TREM2 gene plays a critical role in the immune system, particularly in the brain's immune response. Mutations in this gene are linked to a rare condition known as Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. This genetic disorder is characterized by a combination of bone cysts leading to fractures and progressive neurological deterioration due to leukoencephalopathy, which affects the white matter of the brain.
To diagnose and understand the genetic basis of PLOSL, a genetic test targeting the TREM2 gene can be conducted. This test is crucial for confirming the diagnosis, understanding the risk of transmission to offspring, and guiding management and treatment decisions.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED, making it accessible for those who require this critical diagnostic tool. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for mutations in the TREM2 gene. Results from this test can provide essential insights into the condition, facilitating targeted treatment and management strategies for affected individuals and their families.
The GAA Gene Pompe Disease Genetic Test is a specialized diagnostic procedure designed to identify mutations in the GAA gene, which are responsible for Pompe Disease. This condition, also known as Glycogen Storage Disease Type II, is a rare and often fatal genetic disorder that impairs the body's ability to break down glycogen due to the deficiency of the lysosomal acid alpha-glucosidase enzyme. The accumulation of glycogen in cells, especially muscle cells, leads to progressive muscle weakness, heart and respiratory problems, and, in severe cases, premature death.
The test involves analyzing the patient's DNA to detect mutations in the GAA gene, offering crucial information for the diagnosis, management, and treatment planning of Pompe Disease. It is particularly important for families with a history of the condition, individuals showing symptoms of muscle weakness and respiratory difficulties, and couples considering pregnancy who wish to understand their genetic risks.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the GAA Gene Pompe Disease Genetic Test ensures accuracy and confidentiality, providing patients and healthcare providers with critical insights into this genetic disorder. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology required to accurately identify the GAA gene mutations. This investment can be invaluable for affected families, offering a pathway to early intervention and tailored treatment strategies that can significantly improve quality of life and outcomes for individuals with Pompe Disease.
The TSEN54 gene is associated with a rare genetic disorder known as Pontocerebellar Hypoplasia Type 2A (PCH2A), which affects the development and function of the brain, particularly the pons and cerebellum. This condition is characterized by significant developmental delay, movement problems, and intellectual disability, with symptoms appearing in infancy.
A genetic test specifically designed to identify mutations in the TSEN54 gene can confirm a diagnosis of PCH2A. This test is crucial for families seeking answers about their child's developmental issues, as it can provide definitive evidence of the condition, allowing for better-informed decisions regarding care and management.
In the UAE, this specialized genetic test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The cost of the TSEN54 gene test for Pontocerebellar Hypoplasia Type 2A is 4400 AED. Opting for this test at DNA Labs UAE ensures accuracy and reliability, as the laboratory is equipped with state-of-the-art technology and staffed by professionals experienced in genetic diagnostics. This test is an essential tool for families and healthcare providers in the management and understanding of PCH2A, enabling a targeted approach to treatment and support for affected individuals.
The TSEN2 gene pontocerebellar hypoplasia type 2B genetic test is a specialized diagnostic tool aimed at detecting mutations in the TSEN2 gene, which are linked to pontocerebellar hypoplasia type 2B (PCH2B). PCH2B is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two crucial parts of the brain responsible for movement coordination, balance, and various bodily functions. This condition manifests early in life and is associated with severe neurological impairments.
Conducted at DNA Labs UAE, the test is designed for individuals who are suspected to have PCH2B based on clinical symptoms or for those with a family history of the condition seeking genetic counseling. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for the presence of specific mutations in the TSEN2 gene that are indicative of PCH2B.
The cost of the TSEN2 gene pontocerebellar hypoplasia type 2B genetic test at DNA Labs UAE is 4400 AED. This price may cover the test itself, the expertise of the genetic counselors, and the detailed report provided after analysis. The test's results can offer crucial information for affected families, including the confirmation of a diagnosis, understanding the risk of passing the condition to future generations, and guiding treatment and management decisions. It's an important step in the journey towards personalized medicine and offers hope for better outcomes through targeted interventions.
The TSEN34 Gene Pontocerebellar Hypoplasia Type 2C Genetic Test is a specialized diagnostic tool designed to identify mutations in the TSEN34 gene, which are linked to Pontocerebellar Hypoplasia Type 2C (PCH2C). PCH2C is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two critical regions of the brain responsible for controlling movement and coordination. This condition manifests early in life and can lead to significant neurological impairments, including difficulties with movement, speech, and in some cases, intellectual disabilities.
The test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. Utilizing advanced genomic sequencing technologies, DNA Labs UAE offers this test at a cost of 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in their state-of-the-art laboratory facilities. The aim is to detect any mutations in the TSEN34 gene that may indicate the presence of PCH2C, thereby providing crucial information for diagnosis, management, and familial genetic counseling.
Given the complexity and rarity of Pontocerebellar Hypoplasia Type 2C, the TSEN34 Gene Test is an invaluable resource for affected families seeking answers and medical professionals aiming to tailor care plans to the specific needs of their patients.
The SEPSECS gene pontocerebellar hypoplasia type 2D genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SEPSECS gene, which are associated with pontocerebellar hypoplasia type 2D (PCH2D). PCH2D is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two critical regions of the brain involved in controlling movement and coordination. This condition often presents significant developmental challenges and neurological symptoms from infancy.
DNA Labs UAE offers this genetic test as a crucial tool for healthcare providers and families seeking answers about this specific form of pontocerebellar hypoplasia. By analyzing an individual's DNA, the test can confirm a diagnosis of PCH2D, thus enabling appropriate care and management strategies to be implemented. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the SEPSECS gene.
Undergoing this test at DNA Labs UAE ensures access to state-of-the-art genetic testing services, provided by a team of experts in the field of genetic diagnostics. The results from this test can be pivotal for families in understanding the condition, planning for the future, and connecting with support and resources tailored to their needs.
The VPS53 Gene Pontocerebellar Hypoplasia Type 2E Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the VPS53 gene, which are associated with Pontocerebellar Hypoplasia Type 2E (PCH2E). PCH2E is a rare genetic disorder characterized by the underdevelopment of the cerebellum and brainstem, leading to severe neurological impairments. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test is crucial for early diagnosis, which can help in the management of symptoms and in providing supportive care for affected individuals. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the VPS53 gene.
At DNA Labs UAE, the cost of the VPS53 Gene Pontocerebellar Hypoplasia Type 2E Genetic Test is 4400 AED. Given the complexity of the test and the expertise required to interpret the results, this price reflects the comprehensive service provided by the laboratory, including pre-test counseling, the testing process itself, and post-test interpretation and counseling. This test is an invaluable resource for families with a history of PCH2E, offering them crucial information for understanding their genetic health and making informed decisions.
The PARK7 gene, also known as DJ-1, plays a significant role in protecting cells from oxidative stress and is involved in the regulation of gene expression and mitochondrial function. Mutations in the PARK7 gene are linked to the development of Parkinson's disease, a progressive neurological disorder characterized by tremors, stiffness, and difficulties with balance and coordination.
The PARK7 Parkinson Genetic Test is a specialized diagnostic tool designed to detect mutations in the PARK7 gene. This test is crucial for individuals with a family history of Parkinson's disease or those showing early symptoms of the condition, as it can provide valuable insights into their risk of developing the disease. Early detection through genetic testing can lead to a more tailored approach to treatment and management, potentially improving the quality of life for those affected.
DNA Labs UAE offers the PARK7 Parkinson Genetic Test, ensuring high-quality and accurate genetic analysis. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to perform the analysis. Conducted in a state-of-the-art facility, the test results are provided with comprehensive explanations, making it easier for individuals and their healthcare providers to understand the implications and consider appropriate steps for management or intervention.
The ATP13A2 gene, also known as PARK9, plays a crucial role in the genetic landscape of Parkinson's disease, a progressive neurological disorder that affects movement. Mutations in the ATP13A2 gene are linked to a rare form of Parkinson's disease, often associated with early onset and additional symptoms beyond the classical movement issues, such as cognitive impairment and psychiatric symptoms.
The ATP13A2 Gene PARK9 Parkinson Genetic Test is a specialized diagnostic tool designed to detect mutations in the ATP13A2 gene. This test is particularly relevant for individuals who have a family history of Parkinson's disease or exhibit symptoms at an unusually young age. Identifying mutations in the ATP13A2 gene can aid in the accurate diagnosis of the condition, influence treatment strategies, and provide valuable information for family planning.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE employs state-of-the-art technology and adheres to stringent quality control measures to ensure the accuracy and reliability of their test results.
The cost of the ATP13A2 Gene PARK9 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This price includes the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a comprehensive report detailing the findings. Individuals interested in undergoing this test are advised to consult with a healthcare professional or a genetic counselor to discuss the potential implications of the test results for themselves and their family members.
